EM2601G "Farabursen: Trials, Tribulations, and Translation of a microRNA Therapeutic – A UTSW Bench-to-Clinic Story" (IM GR-01.30.26)

Purpose and Overview

Describe the bench-to-clinic drug discovery story for farabursen, an investigational RNA therapeutic drug for ADPKD.

Target Audience

UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.

Learning Objectives

At the conclusion of this activity, the participant should be able to:

  • Obtain basic insights into ADPKD pathogenesis
  • Appreciate the development life cycle of oligonucleotide drugs for kidney diseases
  • Appreciate the potential for farabursen to be a disease-modifying therapy for ADPKD
Course summary
Available credit: 
  • 1.00 AMA
Course opens: 
02/02/2026
Course expires: 
04/30/2026
Cost:
$0.00
Rating: 
0

Dr. Vishal Patel

Vishal Patel, M.D.
Professor of Internal Medicine
Division of Nephrology
UT Southwestern Medical Center

Available Credit

  • 1.00 AMA

Price

Cost:
$0.00
Please login or create an account to take this course.

Required Hardware/software

Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox and Google Chrome